Advertisement SpectraScience places pre-cancer imaging device at University of Iowa - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

SpectraScience places pre-cancer imaging device at University of Iowa

SpectraScience has placed its Luma cervical imaging system to detect pre-cancers at the University of Iowa in Iowa City.

SpectraScience’s Luma cervical imaging system was developed to significantly improve the detection of high-grade precancerous cervical abnormalities that have the potential to become invasive cancer.

The Luma system provides a safe and effective method, that when used as an adjunct to colposcopy, has been demonstrated to uncover at least 26% more high-grade precancerous disease than colposcopy alone.

Jim Hitchin, CEO of SpectraScience, said: “We are pleased to have placed our Luma System at the prestigious University of Iowa facility and believe that it is a strong validation of our technology. We are committed to developing and bringing more effective cancer screening technologies to the market with the result of better and earlier diagnosis.”